Moneycontrol
YOU ARE HERE > Moneycontrol > Mutual Funds > Evaluate > Performance Tracker : Sector - Pharma & Healthcare
Performance Tracker

Sector - Pharma & Healthcare

Funds with an investment objective to invest in pharmaceutical, healthcare and related sectors.
Sector - Pharma & Healthcare - Returns (in %) - as on Sep 22, 2017
Compare With Indices
  • Sensex
  • Nifty
  • BANK Nifty
  • BANKEX
  • BSE Auto
  • BSE CD INDEX
  • BSE FMCG INDEX
  • BSE HEALTHCARE
  • BSE IPO
  • BSE IT INDEX
  • BSE Metal
  • BSE Oil & Gas
  • BSE POWER INDEX
  • BSE PSU INDEX
  • BSE REALTY
  • BSE TECk INDEX
  • BSE-100
  • BSE-200
  • BSE-500
  • BSE-MIDCAP
  • BSE-SMALLCAP
  • CAPITAL GOODS
  • CNX 100
  • CNX IT
  • CNX Midcap
  • CNX NIFTY JR
  • Nifty Midcap 50
  • S&P CNX 500
  • S&P CNX Defty

Mutual Fund Scheme

Crisil Rank AUM
(Rs. cr.)
Jun 17
1mth 3mth 6mth 1yr 2yr 3yr 5yr  
* Returns over 1 year are Annualised
Sponsored Advt.
Reliance Pharma Fund (G) Not Ranked
1,195.87 9.5 3.8 -1.6 -10.6 -6.6 3.6 15.6
UTI Pharma & Health - Direct (G) Not Ranked
21.28 5.6 0.9 -5.6 -12.3 -6.8 2.3 --
Reliance Pharma Fund - Direct (G) Not Ranked
147.02 9.6 4.1 -1.2 -9.8 -5.8 4.5 --
UTI Pharma & Health (G) Not Ranked
282.74 5.5 0.7 -6.0 -13.1 -7.7 1.3 13.6
Reliance Pharma Fund (G) Not Ranked
1,195.87 9.5 3.8 -1.6 -10.6 -6.6 3.6 15.6
Tata India Pharma & HealthCare -Dir (G) Not Ranked
10.80 5.0 -3.0 -6.0 -13.6 -- -- --
SBI Pharma Fund - Direct (G) Not Ranked
171.28 6.5 1.3 -8.2 -14.7 -6.7 6.2 --
Tata India Pharma & HealthCare - RP (G) Not Ranked
67.80 4.8 -3.5 -6.7 -15.0 -- -- --
SBI Pharma Fund (G) Not Ranked
764.74 6.3 1.0 -8.8 -15.7 -7.9 4.9 17.9
CATEGORY AVERAGE 9.4 2.5 -3.9 -10.9 -4.9 2.9 12.2

Note : Returns have been calculated based on NAV's as on Sep 22, 2017 & Index values as on Sep 22, 2017

As per AMFI guidelines, effective from quarter ending December 31, 2010, fund houses have stopped publishing the Assets Under Management (AUM) on a monthly basis. This data is published every quarter.

Quick Links (Mouseover on for more information)
Sections
Follow us on
Available On